• Abbott published 'Advancing Diversity in Clinical Trials' to share strategies to support diversified clinical trials in healthcare
• The company continues to build new partnerships designed to improve diverse enrollment in clinical trials, drive education about the research process, and empower diverse patients to improve their care
• Now in its third year, Abbott's Diversity in Clinical Trials initiative continues to ensure broad, diverse groups of patients are represented in the clinical trials process

ABBOTT PARK, Ill. – Nov. 19, 2024 – Abbott today announced that, in the third year of its multi-million-dollar Diversity in Clinical Trials initiative, the company has published 'Advancing Diversity in Clinical Trials' to share strategies to make clinical research and the teams leading these trials more diverse across the U.S. Concurrently, Abbott also revealed new partnerships to continue driving diversity in clinical trials by breaking down traditional barriers to care.

Simultaneously published in TIME Magazine, 'Advancing Diversity in Clinical Trials' draws on experiences and insights from a diverse group of nearly 100 experts in the field, including academic researchers, physicians, advocacy groups, clinical trialists, and experts within Abbott. The paper identifies and provides understanding about four key barriers to accessing clinical trials: lack of trust, lack of transparency, lack of access, and lack of a common language. To overcome these challenges, the paper highlights a number of key recommendations, including:

• Researchers should consider impleme…